newsfilter
← Latest News
GlobeNewswire·

Pasithea Therapeutics to Host Virtual KOL Event on NF1 Treatment November 4, 2026

MIAMI, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ:KTTA) ("Pasithea" or the "Company"), a clinical-stage biotechnology company developing PAS-004, a next-generation